Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" [Gynecol. Oncol. 154 (2019) 441-448].

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N.

Gynecol Oncol. 2020 Feb 20. pii: S0090-8258(20)30159-1. doi: 10.1016/j.ygyno.2020.02.023. [Epub ahead of print] No abstract available.

PMID:
32087992
2.

Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.

Connor YD, Miao D, Lin DI, Hayne C, Howitt BE, Dalrymple JL, DeLeonardis KR, Hacker MR, Esselen KM, Shea M.

Gynecol Oncol. 2019 Dec 21. pii: S0090-8258(19)31618-X. doi: 10.1016/j.ygyno.2019.10.031. [Epub ahead of print]

PMID:
31954538
3.

Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.

Hodgson A, Howitt BE, Park KJ, Lindeman N, Nucci MR, Parra-Herran C.

Int J Gynecol Pathol. 2019 Dec 18. doi: 10.1097/PGP.0000000000000665. [Epub ahead of print]

PMID:
31855952
4.

A Potential Diagnostic Pitfall for Hobnail Variant of Papillary Thyroid Carcinoma.

Wong KS, Chen TY, Higgins SE, Howitt BE, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA.

Histopathology. 2019 Dec 7. doi: 10.1111/his.14042. [Epub ahead of print]

PMID:
31811787
5.

SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.

Kolin DL, Quick CM, Dong F, Fletcher CDM, Stewart CJR, Soma A, Hornick JL, Nucci MR, Howitt BE.

Am J Surg Pathol. 2020 Feb;44(2):263-270. doi: 10.1097/PAS.0000000000001375.

PMID:
31567195
6.

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.

de Jonge MM, Ritterhouse LL, de Kroon CD, Vreeswijk MPG, Segal JP, Puranik R, Hollema H, Rookus MA, van Asperen CJ, van Leeuwen FE, Smit VTHBM, Howitt BE, Bosse T; HEBON Group.

Clin Cancer Res. 2019 Dec 15;25(24):7517-7526. doi: 10.1158/1078-0432.CCR-19-0848. Epub 2019 Sep 6.

PMID:
31492746
7.

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N.

Gynecol Oncol. 2019 Aug;154(2):441-448. doi: 10.1016/j.ygyno.2019.04.679. Epub 2019 May 19. Review. Erratum in: Gynecol Oncol. 2020 Feb 20;:.

8.

Practical Issues and Updates in Gynecologic Pathology.

Howitt BE.

Surg Pathol Clin. 2019 Jun;12(2):xi-xii. doi: 10.1016/j.path.2019.03.001. No abstract available.

PMID:
31097118
9.

Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features.

Parra-Herran C, Howitt BE.

Surg Pathol Clin. 2019 Jun;12(2):363-396. doi: 10.1016/j.path.2019.01.004. Review.

PMID:
31097109
10.

Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma.

Costigan DC, Dong F, Nucci MR, Howitt BE.

Int J Gynecol Pathol. 2020 Mar;39(2):119-127. doi: 10.1097/PGP.0000000000000583.

PMID:
30702464
11.

International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.

Hodgson A, Olkhov-Mitsel E, Howitt BE, Nucci MR, Parra-Herran C.

J Clin Pathol. 2019 May;72(5):347-353. doi: 10.1136/jclinpath-2018-205632. Epub 2019 Jan 24.

PMID:
30679193
12.

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.

Ding L, Kim HJ, Wang Q, Kearns M, Jiang T, Ohlson CE, Li BB, Xie S, Liu JF, Stover EH, Howitt BE, Bronson RT, Lazo S, Roberts TM, Freeman GJ, Konstantinopoulos PA, Matulonis UA, Zhao JJ.

Cell Rep. 2018 Dec 11;25(11):2972-2980.e5. doi: 10.1016/j.celrep.2018.11.054.

13.

The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.

Soong TR, Howitt BE, Horowitz N, Nucci MR, Crum CP.

Gynecol Oncol. 2019 Feb;152(2):426-433. doi: 10.1016/j.ygyno.2018.11.033. Epub 2018 Nov 30. Review.

PMID:
30503267
14.

A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.

Kolin DL, Costigan DC, Dong F, Nucci MR, Howitt BE.

Am J Surg Pathol. 2019 Mar;43(3):389-398. doi: 10.1097/PAS.0000000000001193.

PMID:
30489318
15.

Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps.

Strickland KC, Yuan L, Quade BJ, Nucci MR, Howitt BE.

Hum Pathol. 2019 Feb;84:239-245. doi: 10.1016/j.humpath.2018.10.002. Epub 2018 Oct 16.

PMID:
30339971
16.

HPV 6-associated HSIL/Squamous Carcinoma in the Anogenital Tract.

Liu MZ, Hung YP, Huang EC, Howitt BE, Nucci MR, Crum CP.

Int J Gynecol Pathol. 2019 Sep;38(5):493-497. doi: 10.1097/PGP.0000000000000556.

PMID:
30312218
17.

Targeted next-generation sequencing in the detection of mismatch repair deficiency in endometrial cancers.

Dong F, Costigan DC, Howitt BE.

Mod Pathol. 2019 Feb;32(2):252-257. doi: 10.1038/s41379-018-0125-4. Epub 2018 Sep 11.

18.

Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).

Mirkovic J, Dong F, Sholl LM, Garcia E, Lindeman N, MacConaill L, Crum CP, Nucci MR, McCluggage WG, Howitt BE.

Int J Gynecol Pathol. 2019 Nov;38(6):543-551. doi: 10.1097/PGP.0000000000000545.

PMID:
30134342
19.

Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.

Soong TR, Howitt BE, Miron A, Horowitz NS, Campbell F, Feltmate CM, Muto MG, Berkowitz RS, Nucci MR, Xian W, Crum CP.

J Pathol. 2018 Nov;246(3):344-351. doi: 10.1002/path.5145. Epub 2018 Sep 27.

PMID:
30043522
20.

Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.

Barnard ME, Pyden A, Rice MS, Linares M, Tworoger SS, Howitt BE, Meserve EE, Hecht JL.

Gynecol Oncol. 2018 Sep;150(3):521-526. doi: 10.1016/j.ygyno.2018.07.003. Epub 2018 Jul 9.

21.

Evidence of a Monoclonal Origin for Bilateral Serous Tubal Intraepithelial Neoplasia.

Meserve EE, Strickland KC, Miron A, Soong TR, Campbell F, Howitt BE, Crum CP.

Int J Gynecol Pathol. 2019 Sep;38(5):443-448. doi: 10.1097/PGP.0000000000000534.

PMID:
29901519
22.

International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.

Hodgson A, Park KJ, Djordjevic B, Howitt BE, Nucci MR, Oliva E, Stolnicu S, Xu B, Soslow RA, Parra-Herran C.

Am J Surg Pathol. 2019 Jan;43(1):75-83. doi: 10.1097/PAS.0000000000001095.

23.

Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).

Ditzel HM, Strickland KC, Meserve EE, Stover E, Konstantinopoulos PA, Matulonis UA, Muto MG, Liu JF, Feltmate C, Horowitz N, Berkowitz RS, Gupta M, Hecht JL, Lin DI, Jochumsen KM, Welch WR, Hirsch MS, Quade BJ, Lee KR, Crum CP, Mutter GL, Nucci MR, Howitt BE.

Int J Gynecol Pathol. 2019 May;38(3):230-240. doi: 10.1097/PGP.0000000000000513.

PMID:
29750700
24.

SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.

Kolin DL, Dong F, Baltay M, Lindeman N, MacConaill L, Nucci MR, Crum CP, Howitt BE.

Mod Pathol. 2018 Sep;31(9):1442-1456. doi: 10.1038/s41379-018-0049-z. Epub 2018 Apr 26.

25.

Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.

Angell TE, Vyas CM, Barletta JA, Cibas ES, Cho NL, Doherty GM, Gawande AA, Howitt BE, Krane JF, Marqusee E, Strickland KC, Alexander EK, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1410-1417. doi: 10.1245/s10434-018-6421-x. Epub 2018 Mar 8.

PMID:
29520656
26.

Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival.

Markt SC, Tang T, Cronin AM, Katz IT, Howitt BE, Horowitz NS, Lee LJ, Wright AA.

PLoS One. 2018 Feb 15;13(2):e0193047. doi: 10.1371/journal.pone.0193047. eCollection 2018.

27.

Mesonephric proliferations of the female genital tract.

Howitt BE, Nucci MR.

Pathology. 2018 Feb;50(2):141-150. doi: 10.1016/j.pathol.2017.11.084. Epub 2017 Dec 19. Review.

PMID:
29269124
28.

PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Jahanseir K, Xing D, Greipp PT, Sukov WR, Keeney GL, Howitt BE, Schoolmeester JK.

Int J Gynecol Pathol. 2018 Nov;37(6):537-546. doi: 10.1097/PGP.0000000000000472.

29.

Solitary fibrous tumour of the female genital tract: a clinicopathological analysis of 25 cases.

Yang EJ, Howitt BE, Fletcher CDM, Nucci MR.

Histopathology. 2018 Apr;72(5):749-759. doi: 10.1111/his.13430. Epub 2018 Jan 26.

PMID:
29106748
30.

Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.

Mirkovic J, McFarland M, Garcia E, Sholl LM, Lindeman N, MacConaill L, Dong F, Hirsch M, Nucci MR, Quick CM, Crum CP, McCluggage WG, Howitt BE.

Am J Surg Pathol. 2018 Feb;42(2):227-233. doi: 10.1097/PAS.0000000000000958.

PMID:
28984674
31.

Pleomorphic fibroma of the skin with MDM2 immunoreactivity: A potential diagnostic pitfall.

Tashakori M, Pimentel J, Howitt BE, Sanchez J, Michalowski S, Chitale D, Ormsby AH, Williamson SR.

J Cutan Pathol. 2018 Jan;45(1):59-62. doi: 10.1111/cup.13052. Epub 2017 Nov 8.

PMID:
28981153
32.

Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.

Strickland KC, Howitt BE, Barletta JA, Cibas ES, Krane JF.

Cancer Cytopathol. 2018 Feb;126(2):86-93. doi: 10.1002/cncy.21922. Epub 2017 Sep 15.

33.

Criteria for Risk Stratification of Vulvar and Vaginal Smooth Muscle Tumors: An Evaluation of 71 Cases Comparing Proposed Classification Systems.

Sayeed S, Xing D, Jenkins SM, Weisman PS, Buehler D, Warmke L, Uram-Tuculescu C, Bakkum-Gamez JN, Howitt BE, Cortese C, Park KJ, Schoolmeester JK.

Am J Surg Pathol. 2018 Jan;42(1):84-94. doi: 10.1097/PAS.0000000000000920.

34.

Pathology of Neuroendocrine Tumours of the Female Genital Tract.

Howitt BE, Kelly P, McCluggage WG.

Curr Oncol Rep. 2017 Sep;19(9):59. doi: 10.1007/s11912-017-0617-2. Review.

PMID:
28735441
35.

Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women.

Howitt BE, Herfs M, Tomoka T, Kamiza S, Gheit T, Tommasino M, Delvenne P, Crum CP, Milner D.

J Glob Oncol. 2016 Aug 10;3(3):227-234. doi: 10.1200/JGO.2015.001909. eCollection 2017 Jun.

36.

Cervical mesonephric hyperplasia lacks KRAS/NRAS mutations.

Mirkovic J, Schoolmeester JK, Campbell F, Miron A, Nucci MR, Howitt BE.

Histopathology. 2017 Dec;71(6):1003-1005. doi: 10.1111/his.13307. Epub 2017 Sep 19. No abstract available.

PMID:
28703285
37.

Architectural overlap between benign endocervix and pattern-A endocervical adenocarcinoma: Are all pattern-A tumors invasive?

Douglas G, Howitt BE, Schoolmeester JK, Schwartz L, Kos Z, Islam S, Djordjevic B, Parra-Herran C.

Pathol Res Pract. 2017 Jul;213(7):799-803. doi: 10.1016/j.prp.2017.03.008. Epub 2017 Mar 8.

PMID:
28554747
38.

Frequency of "incidental" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study.

Meserve EEK, Mirkovic J, Conner JR, Yang E, Muto MG, Horowitz N, Strickland KC, Howitt BE, Crum CP.

Gynecol Oncol. 2017 Jul;146(1):69-73. doi: 10.1016/j.ygyno.2017.04.015. Epub 2017 May 4.

PMID:
28479065
39.

HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation.

Talia KL, Stewart CJR, Howitt BE, Nucci MR, McCluggage WG.

Am J Surg Pathol. 2017 Aug;41(8):1023-1033. doi: 10.1097/PAS.0000000000000855.

PMID:
28394803
40.

Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: A before and after study.

Liu CY, Elias KM, Howitt BE, Lee LJ, Feltmate CM.

Gynecol Oncol. 2017 May;145(2):248-255. doi: 10.1016/j.ygyno.2017.03.012. Epub 2017 Mar 28.

PMID:
28363672
41.

Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression.

Howitt BE, Strickland KC, Sholl LM, Rodig S, Ritterhouse LL, Chowdhury D, D'Andrea AD, Matulonis UA, Konstantinopoulos PA.

Oncoimmunology. 2017 Jan 6;6(2):e1277308. doi: 10.1080/2162402X.2016.1277308. eCollection 2017.

42.

The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.

Wong KS, Strickland KC, Angell TE, Nehs MA, Alexander EK, Cibas ES, Krane JF, Howitt BE, Barletta JA.

Endocr Pathol. 2017 Jun;28(2):171-176. doi: 10.1007/s12022-017-9476-5.

PMID:
28271380
43.

Predicted neoantigen load in non-hypermutated endometrial cancers: Correlation with outcome and tumor-specific genomic alterations.

Shukla SA, Howitt BE, Wu CJ, Konstantinopoulos PA.

Gynecol Oncol Rep. 2016 Dec 29;19:42-45. doi: 10.1016/j.gore.2016.12.009. eCollection 2017 Feb.

44.

Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.

Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL.

J Am Coll Surg. 2017 Jun;224(6):1021-1027. doi: 10.1016/j.jamcollsurg.2016.12.007. Epub 2016 Dec 23.

PMID:
28017809
45.

Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA.

Watkins JC, Howitt BE, Horowitz NS, Ritterhouse LL, Dong F, MacConaill LE, Garcia E, Lindeman NI, Lee LJ, Berkowitz RS, Nucci MR, Crum CP.

Mod Pathol. 2017 Mar;30(3):448-458. doi: 10.1038/modpathol.2016.187. Epub 2016 Nov 11.

46.

A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma.

Dong F, Davineni PK, Howitt BE, Beck AH.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1511-1516. Epub 2016 Aug 5.

47.

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.

Sheets JN, Iwanicki M, Liu JF, Howitt BE, Hirsch MS, Gubbels JA, Drapkin R, Egland KA.

Oncogenesis. 2016 Oct 24;5(10):e264. doi: 10.1038/oncsis.2016.64.

48.

XXIX. Dr Hazel Mansell Gore.

Howitt BE, Nucci MR, Young RH.

Int J Gynecol Pathol. 2016 Nov;35(6):598-605. No abstract available.

PMID:
27662037
49.

Ovarian cancer.

Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY.

Nat Rev Dis Primers. 2016 Aug 25;2:16061. doi: 10.1038/nrdp.2016.61. Review.

PMID:
27558151
50.

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.

Watkins JC, Yang EJ, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS, Syngal S, Yurgelun MB, Chittenden A, Hornick JL, Crum CP, Sholl LM, Howitt BE.

Int J Gynecol Pathol. 2017 Mar;36(2):115-127. doi: 10.1097/PGP.0000000000000312.

PMID:
27556954

Supplemental Content

Loading ...
Support Center